Induction and direction of immune responses by vaccine adjuvants

Critical Reviews in Immunology

Volumn 21, Issue 1-3, 2001, Pages 75-85

  Schijns, V E J C ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

Adjuvant; Danger; Delivery; Dendritic cell; Immunity; Signal 0; Tolerance; Vaccine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; VACCINE;

ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOREACTIVITY; IMMUNOREGULATION; LYMPH NODE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; CYTOKINES; DENDRITIC CELLS; DRUG DESIGN; HUMANS; IMMUNITY; T-LYMPHOCYTES; VACCINES;

EID: 0034793816     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (75)

1. A new analysis of allogenic interactions
2. Antigen localization regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
3. The immune system evolved to discriminate infectious nonself from noninfectious self
4. Tolerance, danger and the extended family
5. Adjuvants - A balance between toxicity and adjuvanticity
6. Approaching the asymptote? Evolution and revolution in immunology
7. Homing of naïve, memory and effector lymphocytes
8. Lymphocyte homing and homeostasis
9. Immune responses in the absence of costimulation: Viruses know the trick
10. -/-) mutant mice
11. Constitutive class-I restricted exogenous presentation of self antigens in vivo
12. Experimental studies on the pathogenesis of contact eczema in the guinea pig
13. The role of regional lymphatics in the skin homograft response
14. Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response
15. Dendritic cells and the control of immunity
16. Dendritic cells: Nature's adjuvant
17. Dendritic cells: Nature's adjuvants
18. Dendritic cell loss from nonlymphoid tissue after systemic administration of lipopolysaccharide, tumour necrosis factor, and interleukin 1
19. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
20. Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant
21. Dendritic cells internalize vaccine adjuvant after intramuscular injection
22. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
23. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli
24. Genetic fusion of chemokines to a self-tumor antigen induces protective, T-cell dependent antitumor immunity
25. Macrophage inflammatory protein-alpha expression plasmid enhances DNA vaccine-induced immune response against HIV-1
26. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1 specific immunity
27. The mode of action of mineral oil emulsion adjuvants on antibody production in mice
28. Immunological adjuvants: A role for liposomes
29. The mechanism of the adjuvant effect of dextran sulfate
30. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
31. Duration of TCR stimulation determines costimulatory requirement of T cells
32. The maintenance and regulation of the humoral immune response: Persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells
33. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil
34. Recent advances in the study of dendritic cells and follicular dendritic cells
35. The mode of action of immunologic adjuvants
36. 26AL
37. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo
38. Immunogenicity signals 1,2,3 ... and 0
39. Immunological tolerance: Danger - Pathogen on the premises!
40. The instructive role of innate immunity in the acquired immune response
41. Dependence of the adaptive immune response on innate immunity. Some questions answered but new paradoxes emerge
42. A human homologue of the Drosophila toll protein signals activation of adaptive immunity
43. Innate immunity: The virtues of a nonclonal recognition system
44. New meanings for an old word: Adjuvanticity, cytokines and T cells
45. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles
46. Comparison of tissue reactions produced by Haemophilus pleuropneumonia vaccines made with six different adjuvants in swine
47. Pathological studies on local tissue reactions in guinea pigs and rats caused by four different adjuvants
48. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties
49. 3C) conjugates
50. Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells
51. Teetering on the brink of danger
52. Natural adjuvants: Endogenous activators of dendritic cells
53. Towards a unified theory of immunity: Dendritic cells, stress proteins and antigenic capture
54. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
55. + CTL effector cells in mice by immunization with a stress protein - Influenza nucleoprotein fusion molecule
56. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
57. Costimulation of antitumor immunity by B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
58. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
59. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments antitumor efficacy
60. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA4 antibodies
61. Will adjuvants be needed for vaccines of the future?
62. + T cells
63. Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants
64. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production
65. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-γ
66. Cytokines as potential vaccine adjuvants
67. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
68. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin
69. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
70. Lipid vesicle-entrapped influenza A antigen modulates the influenza-specific human antibody response in immune reconstituted SCID human mice
71. H2 response to entrapped antigen
72. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
73. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
74. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
75. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue